BNC1 is a zinc finger transcription factor that functions as a transcriptional activator with critical roles in reproductive and somatic development. In oocytes, BNC1 maintains ovarian reserve by regulating lipid metabolism and redox homeostasis, with BNC1 deficiency triggering ferroptosis via the NF2-YAP pathway, leading to premature follicular activation and atresia 1. BNC1 is required for spermatogenesis maintenance [UniProt annotation], and heterozygous truncating variants in BNC1 cause severe oligozoospermia in males 2. Beyond reproduction, BNC1 regulates epicardial cell heterogeneity during cardiac development through a transcriptional network with WT1 and TCF21 3. BNC1 functions as a tumor suppressor in gastric cancer by directly repressing CCL20 expression and inhibiting JAK-STAT signaling 4, and in lung adenocarcinoma, HSF2BP modulates BNC1 expression to regulate tumor proliferation and immune responses 5. Clinically, BNC1 mutations cause primary ovarian insufficiency (POI), affecting ~29% of POI cases in large cohorts 67. YAP and ferroptosis inhibitors represent potential therapeutic approaches for BNC1-deficiency-related POI 1.